Abhijeet Pataskar

Abhijeet Pataskar

Auto-generated profile, based on publicly available information

Abhijeet Pataskar

Institute of Molecular Biology (IMB), Mainz, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2015 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
APAbhijeet Pataskar
Abhijeet Pataskar
JJJohannes Jung
Johannes Jung
PSPawel Smialowski
Pawel Smialowski
FNFlorian Noack
Florian Noack
FCFederico Calegari
Federico Calegari
VTVijay K Tiwari
Vijay K Tiwari
Cell fate specification relies on the action of critical transcription factors that become available at distinct stages of embryonic development. One such factor is NeuroD1, which is essential for eliciting the neuronal development program and possesses the ability to reprogram other cell types into neurons. Given this capacity, it is important to understand its targets and the mechanism underlying neuronal specification. Here, we show that NeuroD1 directly binds regulatory elements of neuronal genes that are developmentally silenced by epigenetic mechanisms. This targeting is sufficient to initiate events that confer transcriptional competence, including reprogramming of transcription factor landscape, conversion of heterochromatin to euchromatin, and increased chromatin accessibility, indicating potential pioneer factor ability of NeuroD1. The transcriptional induction of neuronal fate genes is maintained via epigenetic memory despite a transient NeuroD1 induction during neurogenesis. NeuroD1 also induces genes involved in the epithelial‐to‐mesenchymal transition, thereby promoting neuronal migration. Our study not only reveals the NeuroD1‐dependent gene regulatory program driving neurogenesis but also increases our understanding of how cell fate specification during development involves a concerted action of transcription factors and epigenetic mechanisms. Synopsis Using a genome‐wide approach this study delineates the binding requirements and target sites for NeuroD1, illustrating how this factor drives the formation of a transcriptional and epigenetic program to ensure neuronal differentiation. Genome‐wide assessment of NeuroD1 binding reveals its targeting to regulatory elements of critical neuronal development genes. Following expression, NeuroD1 locates to and binds its target genomic locations in a highly sequence‐specific fashion. Prior to NeuroD1 binding, its target sites are developmentally silenced by epigenetic mechanisms and regulatory factors. NeuroD1 binding initiates events that confer transcriptional competence to neuronal fate genes including conversion of heterochromatin to euchromatin and reprogramming of the transcription factor landscape. The transient action of NeuroD1 during neuronal development is sufficient to induce a neuronal gene expression program that is maintained by epigenetic mechanisms.

18 June 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
MKMarisa Karow
Marisa Karow
JCJ. Gray Camp
J. Gray Camp
SFSven Falk
Sven Falk
TGTobias Gerber
Tobias Gerber
APAbhijeet Pataskar
Abhijeet Pataskar
BBBenedikt Berninger
Benedikt Berninger

15 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SSSanjeeb Kumar Sahu
Sanjeeb Kumar Sahu
NTNeha Tiwari
Neha Tiwari
APAbhijeet Pataskar
Abhijeet Pataskar
YZYuan Zhuang
Yuan Zhuang
MBMarina Borisova
Marina Borisova
VTVijay K. Tiwari
Vijay K. Tiwari
The set of events that convert adherent epithelial cells into migratory cells are collectively known as epithelial–mesenchymal transition (EMT). EMT is involved during development, for example, in triggering neural crest migration, and in pathogenesis such as metastasis. Here we discover FBXO32, an E3 ubiquitin ligase, to be critical for hallmark gene expression and phenotypic changes underlying EMT. Interestingly, FBXO32 directly ubiquitinates CtBP1, which is required for its stability and nuclear retention. This is essential for epigenetic remodeling and transcriptional induction of CtBP1 target genes, which create a suitable microenvironment for EMT progression. FBXO32 is also amplified in metastatic cancers and its depletion in a NSG mouse xenograft model inhibits tumor growth and metastasis. In addition, FBXO32 is essential for neuronal EMT during brain development. Together, these findings establish that FBXO32 acts as an upstream regulator of EMT by governing the gene expression program underlying this process during development and disease.

6 June 2016 in Scientific Reports
Verified
Journal Article
Open access
PKPandurang Kolekar
Pandurang Kolekar
APAbhijeet Pataskar
Abhijeet Pataskar
UKUrmila Kulkarni-Kale
Urmila Kulkarni-Kale
JPJayanta K Pal
Jayanta K Pal
AKAbhijeet Kulkarni
Abhijeet Kulkarni
Cellular mRNAs are predominantly translated in a cap-dependent manner. However, some viral and a subset of cellular mRNAs initiate their translation in a cap-independent manner. This requires presence of a structured RNA element, known as, Internal Ribosome Entry Site (IRES) in their 5′ untranslated regions (UTRs). Experimental demonstration of IRES in UTR remains a challenging task. Computational prediction of IRES merely based on sequence and structure conservation is also difficult, particularly for cellular IRES. A web server, IRESPred is developed for prediction of both viral and cellular IRES using Support Vector Machine (SVM). The predictive model was built using 35 features that are based on sequence and structural properties of UTRs and the probabilities of interactions between UTR and small subunit ribosomal proteins (SSRPs). The model was found to have 75.51% accuracy, 75.75% sensitivity, 75.25% specificity, 75.75% precision and Matthews Correlation Coefficient (MCC) of 0.51 in blind testing. IRESPred was found to perform better than the only available viral IRES prediction server, VIPS. The IRESPred server is freely available at http://bioinfo.net.in/IRESPred/.

23 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
MNMohit Navandar
Mohit Navandar
AGAngela Garding
Angela Garding
SSSanjeeb Kumar Sahu
Sanjeeb Kumar Sahu
APAbhijeet Pataskar
Abhijeet Pataskar
SSSandra Schick
Sandra Schick
VTVijay K. Tiwari
Vijay K. Tiwari
ERK signalling modulates epigenome to drive epithelial to mesenchymal transition ERK signalling modulates epigenome to drive epithelial to mesenchymal transition

28 January 2016 in Developmental Neurobiology
Verified
Journal Article
Closed access
PDF file
SSSabine Stanzel
Sabine Stanzel
JSJutta Stubbusch
Jutta Stubbusch
APAbhijeet Pataskar
Abhijeet Pataskar
MHMarthe J. Howard
Marthe J. Howard
TDThomas Deller
Thomas Deller
KTKonstantina Tsarovina
Konstantina Tsarovina